Skip to search boxSkip to navigationSkip to main content

Dendrimer-based RNA interference delivery for cancer therapy

  • Virginia Commonwealth University
Scholary Output:
Chapter in Book/Report/Conference proceeding
Conference contribution

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

RNA interference (RNAi) has emerged as a promising tool for cancer treatment. A strenuous ongoing effort for translation of RNAi into clinically acceptable therapy is the development of vectors for efficient and targeted RNAi delivery. In this chapter, we review RNAi-based cancer treatment and the utility of dendrimers in RNAi delivery.

Publication Information

Output type

Scholary Output:
Chapter in Book/Report/Conference proceeding
Conference contribution

Original language

English (US)

Pages from-to (Number of pages)

Pages 197-213 (17 pages)

Publication milestones

  • Published - 07/08/2013

Publication status

Published - 07/08/2013

Publisher

American Chemical Society

Publication series

  • Publication series name: ACS Symposium Series
    ISSN (Print): 0097-6156
    ISSN (Electronic): 1947-5918
    Volume: 1135

ISBN (Print)

9780841227989

Publication IDs

  • Scopus: 84905397389

Host publication title

Tailored Polymer Architectures for Pharmaceutical and Biomedical Applications

Access to documents

Publication metrics

Metrics

Scopus
citations
12, opens in new tab
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1
SciVal
FWCI
1.11
SciVal
Author count
3
SciVal
citations
8
SciVal
Paper percentile
62

PlumX, opens in new tab

Citation count
11
Usage
8
Captures
14